Mar 4, 2008|
US economy, petrodollars & more...
With the Union Budget hogging the limelight last week, markets lost no time in shrugging of the impact of the same on Monday as US recession fears continued to haunt the global stockmarkets including India. While the Dow tanked 3% on Friday, Asian indices such as the Nikkei (down 4%), the Hang Seng and the Strait Times (down 3% each) also closed into the red. This spilled over to the Indian stock market as well with the BSE-Sensex
recording a fall of 939 points (down 5%). This week is an economic data laden week for the US, which will give some indication of whether the concerns regarding the US economy slipping into a recession are indeed founded. The most important amongst them is the February jobs report to be released on Friday. It may be noted that the January data reported a net jobs loss (the first in almost four years) and a decline in payrolls is expected in February as well.
Meanwhile, the subprime crisis claimed one more victim on Friday namely American Insurer Group, which is US' largest insurer. The company reported a gargantuan loss of US$ 5.3 bn during the fourth quarter and thereby etched its name in the book of subprime casualties, which includes the likes of Citigroup, Merrill Lynch, Societe Generale amongst others. As a result, volatility and uncertainty has loomed large in stockmarkets the world over and this has been afflicting the Indian stockmarket as well, which continues to grope for direction.
Oil prices do not seem to abate as emerging markets like China and India continue to guzzle oil to support their rapidly expanding economies. With the oil prices touching the psychological US$ 100 per barrel mark, the same is expected to boost the flow of capital into petrodollars. As per Morgan Stanley, at the current pace of production and exports and oil at US$ 100 a barrel, the GCC, non-GCC OPEC and other oil-exporting countries are projected to earn a total of US$ 2.1 trillion annually. While these petrodollars have been utilised for investments in infrastructure in the Gulf countries, a large part of them have been invested in global financial markets thereby creating huge liquidity. Thus, creation of asset bubbles in the future cannot be ruled out if petrodollars relentlessly keep pouring into various asset classes.
The Union Budget proved to be friendly to the pharmaceutical sector by halving the excise duty on all pharma goods from the current 16% to 8%. This is a huge positive for the companies as the excise duty is being paid on the MRP (maximum retail price) of the drug thereby putting pressure on margins. It must be noted that competition in the pharmaceutical industry both in India and abroad is intense and in India, the top player (i.e. GSK Pharma) barely enjoys 6% market share. Besides this, relentless pricing pressure has become a regular feature in the global generics space largely attributed to more and more players vying for a slice of the generics pie. In this scenario, a let up in excise duty is certainly beneficial to companies operating in the domestic market and will provide some breathing relief on the margins front.
The reduction of customs duty on all life saving drugs from 10% to 5% is also a boon and will enable pharma companies to lower prices of these drugs, an act which the pharma industry considers more apt than the price control imposed by the DPCO.
More Views on News
Jun 10, 2017
Forty Indian investing gurus, as worthy of imitation as the legendary Peter Lynch, can help you get rich in the stock market.
Aug 23, 2017
Nowhere was the darkness deeper than in the nation's capital. There, no light shone. No flicker of awareness...observation...learning...or reflection appeared.
Aug 22, 2017
It's surprising Warren Buffett hasn't warned investors about the expensive stock market? Let us know why.
Aug 22, 2017
Post demonetisation, a cut in bank savings deposits rates was in the offing.
Aug 22, 2017
Today, we are attacked by one preposterous thing after another, each of them even more absurd than the last.
More Views on News
Aug 17, 2017
A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.
Aug 10, 2017
Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.
Aug 12, 2017
The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.
Aug 10, 2017
Bitcoin hits an all-time high, is there more upside left?
Aug 16, 2017
Ensure your financial Independence, and pledge to start the journey towards financial freedom today!
Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement. LEGAL DISCLAIMER:
Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here
. The performance data quoted represents past performance and does not guarantee future results.SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: firstname.lastname@example.org. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407